Saianand Commercial Limited is an India-based company. The Company is not engaged in any activity. It does not generate any revenue. The management is looking for an opportunity to make the Company operational.

Employees

Sector

Investment Holding Companies

More about the company

Quotes

Date	Price	Change	Volume
07/09/26	₹0.2100	0.00%	117,641
04/09/26	₹0.2100	0.00%	392,229
03/09/26	₹0.2100	0.00%	191,066
02/09/26	₹0.2100	0.00%	142,626
01/09/26	₹0.2100	+5.00%	113,939

Delayed Quote Bombay S.E.

More quotes

Delayed Bombay S.E. 16:45:02 07/09/2026 HKT			5-day change	1st Jan Change
0.2100 ^INR	0.00%		+5.00%	-30.00%

08-07	Saianand Commercial Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-15	Saianand Commercial Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Market Cap	47.71M 505K 435K 409K 374K 699K 701K 4.83M 1.88M 24.48M 1.9M 1.86M 78.86M	P/E 2024	21.7x	P/E 2025	22.4x
Enterprise Value	73.38M 777K 669K 629K 575K 1.08M 1.08M 7.44M 2.89M 37.65M 2.92M 2.85M 121M	EV / Sales 2024	2,721,280x	EV / Sales 2025	4,249,293x
Free-Float	90.12%	Yield 2024 *	-	Yield 2025	-

08-07	Saianand Commercial Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-15	Saianand Commercial Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
01-30	Saianand Commercial Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11-06	Saianand Commercial Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
28/07/25	Saianand Commercial Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
21/05/25	Saianand Commercial Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025	CI
31/01/25	Saianand Commercial Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
28/01/25	Swagtam Trading & Services Limited announced that it expects to receive INR 61.904375 million in funding from Jalees Commercial Limited, Shree Ganesh Bio-Tech Limited, Amerise Biosciences Limited, Saianand Commercial Limited and other investors	CI
16/01/25	Saianand Commercial Limited Approves Resignation of Komal Chauhan as Independent Director	CI
12/11/24	Saianand Commercial Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
10/09/24	Kunal H. Kothari, Prachi and Tejas K. Rathod completed the acquisition of 67.61% stake in Lucent Industries Limited from a group of shareholders.	CI
13/08/24	Saianand Commercial Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
30/05/24	Saianand Commercial Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

1 week	+5.00%
Current month	+5.00%
1 month	-4.55%
3 months	-8.70%
6 months	-25.00%
Current year	-30.00%

Saianand Commercial Limited Stock

Stocks

SAICOM

INE092G01024

Investment Holding Companies

Valuation : Saianand Commercial Limited

Chart: Saianand Commercial Limited

Latest news : Saianand Commercial Limited

Quotes and Performance

Price Extremes

Managers and Directors : Saianand Commercial Limited

Shell Companies

Financials

Company Profile

Quotes

1 week	0.2	0.21
1 month	0.2	0.25
Current year	0.2	0.31
1 year	0.2	0.39
3 years	0.2	0.95
5 years	0.2	1.04
10 years	0.2	1.04

Manager	Title	Age	Since
Milanbhai Rameshbhai Khatri DFI	Director of Finance/CFO	43	26/12/2023
Bhagyashree Vinayak SEC	Corporate Secretary	-	30/05/2022

Director	Title	Age	Since
Gaurangkumar V. Vaishnav BRD	Director/Board Member	34	07/03/2019
Narendra Kumar Vaniya BRD	Director/Board Member	34	05/08/2022
Kajal Milan Khatri BRD	Director/Board Member	39	26/12/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAIANAND COMMERCIAL LIMITED	0.00%	+5.00%	-34.38%	-51.16%	505K
PASQAL HOLDING SA	-18.36%	-58.35%	-	-	1.69B
CHURCHILL CAPITAL CORP XI	-3.04%	-4.08%	-	-	746M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	0.00%	+0.30%	-	-	648M
BAIN CAPITAL GSS INVESTMENT CORP.	+0.34%	+0.34%	-	-	602M
CHURCHILL CAPITAL CORP XII	-0.70%	-1.11%	-	-	595M
CANTOR EQUITY PARTNERS IV, INC.	+0.10%	+0.39%	+2.87%	-	594M
CENTIEL AG	+0.71%	-2.43%	+246.49%	-79.19%	564M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.87%	-0.78%	-	-	564M
Average	-2.42%	-7.53%	+71.66%	-65.17%	667.23M
Weighted average by Cap.	-5.58%	-17.42%	+121.46%	-79.16%

	2024	2025
Net sales	54.23 0.57 0.49 0.47 0.42 0.79 0.8 5.5 2.13 27.82 2.16 2.11 89.64	24.75 0.26 0.23 0.21 0.19 0.36 0.36 2.51 0.97 12.7 0.98 0.96 40.92
Net income	7.59M 80.39K 69.17K 65.08K 59.45K 111K 112K 769K 298K 3.89M 302K 295K 12.55M	3.56M 37.67K 32.42K 30.5K 27.86K 52.12K 52.26K 360K 140K 1.82M 141K 138K 5.88M
Net Debt	-105K -1.11K -956.96 -900.37 -822.49 -1.54K -1.54K -10.64K -4.13K -53.87K -4.18K -4.08K -174K	25.67M 272K 234K 220K 201K 376K 377K 2.6M 1.01M 13.17M 1.02M 999K 42.42M